Immunotherapy "Shock" with vitiligo due to nivolumab administration as third line therapy in lung adenocarcinoma.
about
Immunotherapy "Shock" with vitiligo due to nivolumab administration as third line therapy in lung adenocarcinoma.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Immunotherapy "Shock" with vit ...... herapy in lung adenocarcinoma.
@en
Immunotherapy "Shock" with vit ...... herapy in lung adenocarcinoma.
@nl
type
label
Immunotherapy "Shock" with vit ...... herapy in lung adenocarcinoma.
@en
Immunotherapy "Shock" with vit ...... herapy in lung adenocarcinoma.
@nl
prefLabel
Immunotherapy "Shock" with vit ...... herapy in lung adenocarcinoma.
@en
Immunotherapy "Shock" with vit ...... herapy in lung adenocarcinoma.
@nl
P2093
P2860
P50
P1476
Immunotherapy "Shock" with vit ...... herapy in lung adenocarcinoma.
@en
P2093
Aggeliki Rapti
Anastasios Kallianos
Dimitrios Drougas
Dimitrios Hatzibougias
Haidong Huang
Lemonia Veletza
Liana Papaemmanouil
Paul Zarogoulidis
Theodora Tsiouda
P2860
P304
P356
10.1016/J.RMCR.2017.10.006
P577
2017-10-26T00:00:00Z